---
pmid: '35989368'
title: CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing
  RNA binding protein FXR1.
authors:
- Ling H
- Cao CH
- Han K
- Lv YR
- Ma XD
- Cao JH
- Chen JW
- Li S
- Lin JL
- Fang YJ
- Pan ZZ
- Xie D
- Wang FW
journal: Oncogene
year: '2022'
full_text_available: false
doi: 10.1038/s41388-022-02439-y
---

# CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1.
**Authors:** Ling H, Cao CH, Han K, Lv YR, Ma XD, Cao JH, Chen JW, Li S, Lin JL, Fang YJ, Pan ZZ, Xie D, Wang FW
**Journal:** Oncogene (2022)
**DOI:** [10.1038/s41388-022-02439-y](https://doi.org/10.1038/s41388-022-02439-y)

## Abstract

1. Oncogene. 2022 Sep;41(39):4433-4445. doi: 10.1038/s41388-022-02439-y. Epub
2022  Aug 22.

CEP63 upregulates YAP1 to promote colorectal cancer progression through 
stabilizing RNA binding protein FXR1.

Ling H(#)(1), Cao CH(#)(1)(2), Han K(#)(1)(3), Lv YR(#)(1), Ma XD(1), Cao JH(1), 
Chen JW(1)(4), Li S(1), Lin JL(1), Fang YJ(1)(3), Pan ZZ(1)(3), Xie D(5)(6), 
Wang FW(7).

Author information:
(1)Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in 
South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 
510060, China.
(2)Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer 
Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of 
Electronic Science and Technology of China, Chengdu, 610041, China.
(3)Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, 
Guangzhou, 510060, China.
(4)Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 
510060, China.
(5)Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in 
South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 
510060, China. xiedan@sysucc.org.cn.
(6)Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, 
510060, China. xiedan@sysucc.org.cn.
(7)Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in 
South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 
510060, China. wangfengw@sysucc.org.cn.
(#)Contributed equally

Abnormal regulation of centrosome components can induce chromosome instability 
and tumorigenesis. Centrosomal protein 63 (CEP63) is a vital member for 
assembling centrosome. Yet, the involvement of CEP63 in cancer pathogenesis 
remains unclear. Here we identify CEP63 as an important mediator for RNA-binding 
proteins (RBPs) to facilitate regulation on their RNA targets in colorectal 
cancer (CRC). We demonstrate that CEP63 protein is upregulated in a large cohort 
of colorectal cancer tissues and predicts poor prognosis, and USP36 is 
identified for stabilizing CEP63 by enhancing its K48-dependent 
deubiquitination. CEP63 overexpression promotes the proliferation and tumor 
growth of CRC cells in vitro and in vivo. Furthermore, we find that CEP63 can 
promote cancer stem-like cell properties by enhancing YAP1 expression through 
binding with and inhibiting the K63-ubiquitylation degradation of RBP FXR1 in 
CRC cells. Importantly, we further verify that the KH domain of FXR1 is 
necessary for the interaction between CEP63 and FXR1. Moreover, microtube motor 
proteins can form a complex with CEP63 and FXR1 to mediate the regulation of 
FXR1 on RNA targets. Additionally, we also confirm that CEP63 can bind and 
regulate multiple RBPs. In conclusion, our findings unveil an unrecognized 
CEP63/RBPs/RNA axis that CEP63 may perform as an adapter facilitating the 
formation of RBPs complex to regulate RNA progression and discover the role of 
CEP63 involved in signal transduction and RNA regulation, providing potential 
therapeutic target for CRC patients.

Â© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

DOI: 10.1038/s41388-022-02439-y
PMID: 35989368 [Indexed for MEDLINE]
